" (SPN, 1) This is to suggest that there are drug therapies available which could significantly improve the quality of life and expectancy for the patient at the center of this case study. However, these are also fundamentally less cost effective measures and approaches which would certainly not be available to those with limited or lacking insurance coverage. Cost effective ways of contending with Multiple Sclerosis therefore tend increasingly to be those methods which detect the condition early and begin limited therapy that can head off its severity at the pass. According to the source provided by the MS Network, "the aim of multiple sclerosis (MS) treatment should be to stabilize patients on a low disability (low cost) level at an early stage of the disease utilizing a cost-effective therapy." (Infonicks, 1) Naturally, this is not always possible. Indeed, in the case of the patient in question, it is clear that the condition has at least advanced enough to cause physical and emotional depression. As a result, treating the condition with the types of indirect muscle therapy and symptom-treating drugs that might be employed...

Any therapeutic efforts which can improve the conditions of this patient in the early going may significantly reduce both the condition's severity and its long-term cost to the system and patient.
Works Cited:

Cohen, E., & Cesta, T. (2005) Nursing case management: Advanced practice applications (4th ed.) Philadelphia: Mosby.

Infonicks. (2007). The Cost of Multiple Sclerosis. MS-Network.

Kobelt, G.; Berg, J.; Atherley, D.: Hadjimichael, O. & Bengt, J. (2005). Case and Quality of Life in Multiple Sclerosis a Cross-Sectional Study in the U.S.A. IDEAS. Online at http://ideas.repec.org/p/hhs/hastef/0594.html

Specialty Pharmacy News (SPN). (2007). Costs Increase for Multiple Sclerosis Therapies. AIS Health. Online at http://www.aishealth.com/PressReleases/bnow0607pr.html